tiprankstipranks
Trending News
More News >
BrightPath Biotherapeutics Co.Ltd. (JP:4594)
:4594
Japanese Market

BrightPath Biotherapeutics Co.Ltd. (4594) Income Statement

Compare
0 Followers

BrightPath Biotherapeutics Co.Ltd. Income Statement

Last quarter (Q3 2023), BrightPath Biotherapeutics Co.Ltd.'s total revenue was ¥23.00K, a decrease of -99.54% from the same quarter last year. In Q3, BrightPath Biotherapeutics Co.Ltd.'s net income was ¥-399.84M. See BrightPath Biotherapeutics Co.Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.13M¥ 72.00K¥ 5.28M¥ 15.41M¥ 2.50M
Gross Profit
¥ 1.10M¥ -341.00K¥ 3.38M¥ 12.09M¥ 1.36M
Operating Expenses
¥ 1.16B¥ 1.15B¥ 1.47B¥ 1.49B¥ 1.73B
Depreciation and Amortization
¥ 1.16B¥ 395.00K¥ 16.72M¥ 35.12M¥ 66.69M
EBITDA
¥ -1.15B¥ -1.17B¥ -1.47B¥ -1.45B¥ -1.65B
Operating Income
¥ -1.16B¥ -1.16B¥ -1.47B¥ -1.48B¥ -1.73B
Other Income/Expenses
¥ 11.67M¥ -11.10M¥ -16.67M¥ -5.74M¥ 15.59M
Pretax Income
¥ -1.15B¥ -1.17B¥ -1.48B¥ -1.48B¥ -1.72B
Net Income
¥ -1.15B¥ -1.17B¥ -1.49B¥ -1.48B¥ -1.72B
Per Share Metrics
Basic EPS
¥ -14.12¥ -18.21¥ -24.90¥ -28.55¥ -36.14
Diluted EPS
¥ -14.12¥ -18.21¥ -24.90¥ -28.55¥ -36.14
Weighted Average Shares Outstanding
81.51M 64.16M 59.66M 51.99M 47.58M
Weighted Average Shares Outstanding (Diluted)
81.51M 64.16M 59.66M 51.99M 47.58M
Currency in JPY

BrightPath Biotherapeutics Co.Ltd. Earnings and Revenue History